Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts.
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
We have reported that short calcitonin (CT) treatment of mature mouse osteoclast-like cells (OCLs) in culture induced prolonged down-regulation of the CT receptor (CTR) and desensitization to CT rechallenge, at the level of adenylate cyclase activity. In this study, we have extended those studies to examine the bone resorbing activity of OCLs pretreated with CT. OCLs, which formed on gelled type I collagen, were pretreated with salmon CT (sCT)(10(-9)M, 1 h) and 24 h later were replated onto plastic dishes or dentine slices after removal from the gel by collagenase digestion. The number and population of either mononuclear or multinuclear OCLs that adhere to either surface was not affected by sCT pretreatment. It was found that OCLs pretreated with sCT regained reduced but significant bone resorbing capacity, which was quantitated as the surface area resorbed by OCLs on dentine slices. However, compared with control, the number of resorption pits produced by sCT- pretreated OCLs was slightly reduced, and the total pit area was decreased by approximately 40-50%. The distribution of individual pit sizes was altered by sCT-pretreatment so that the number of larger pits was predominantly reduced, suggesting that short sCT treatment may produce a long lasting decrease in osteoclast mobility. sCT was able to inhibit bone resorption activity of CT-pretreated OCLs (ED50:10(-13)-10(-12)M). Importantly, the ED50 of sCT inhibition of bone resorption in sCT-pretreated OCLs was approximately 100-fold greater than for control, indicating resistance of the OCLs to CT rechallenge. Consistent with these results, treatment of OCLs with sCT greatly decreased the expression of CTR messenger RNA, whereas no significant effect was observed on the tartrate-resistant acid phosphatase messenger RNA expression, a marker of resorptive capacity of osteoclasts. These results indicate, therefore, that an important component of escape of osteoclastic resorption from CT inhibition is CT resistance of mature osteoclasts, which regain bone resorbing function.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The desensitization of the cells to calcitonin was found to be the result of a ligand-induced internalization of the CTR, as well as inhibition of de novo synthesis of the receptor, and has been confirmed in both human and murine osteoclast cultures (194,212).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [212]
In the citing paper
“A short pretreatment of mature mouse osteoclasts with sCT had no effect on the number of mononuclear or multinuclear osteoclasts that developed in cul-ture but reduced the capacity of the pretreated cells to resorb bone (212).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [212]
Citations
Cites
Ciabarra, A., Sullivan, J., Gahn, L., Pecht, G., Heinemann, S., & Sevarino, K. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-10-06498.1995 · Cited by 1,233
Modulation of Osteoclast Differentiation
SUDA, T., TAKAHASHI, N., & MARTIN, T. J. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-66 · Cited by 1,004
Self-citationTAKAHASHI, N., AKATSU, T., SASAKI, T., NICHOLSON, G. C., MOSELEY, J. M., JOHN MARTIN, T., & SUDA, T. (1988) · Endocrinology · doi:10.1210/endo-123-3-1504 · Cited by 168
Self-citationWENER, J. A., GORTON, S. J., & RAISŹ, L. G. (1972) · Endocrinology · doi:10.1210/endo-90-3-752 · Cited by 152
Calcitonin receptor isoforms in mouse and rat osteoclasts
Ikegame, M., Rakopoulos, M., Zhou, H., Houssami, S., Martin, J. T., Moseley, J. M., & Findlay, D. M. (1995) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650100110 · Cited by 62
Self-citationBOYDE, A., & Jones, S. J. (1991) · Calcified Tissue International · doi:10.1007/bf02565123 · Cited by 61
Wada, S. (1995) · Endocrinology · doi:10.1210/en.136.6.2611 · Cited by 55
Self-citationWada, S. (1996) · Endocrinology · doi:10.1210/en.137.1.312 · Cited by 45
Self-citationGlucocorticoid regulation of calcitonin receptor in mouse osteoclast-like multinucleated cells
Wada, S., Akatsu, T., Tamura, T., Takahashi, N., Suda, T., & Nagata, N. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091106 · Cited by 26
Self-citation
Cited by
The role of peptides and receptors of the calcitonin family in the regulation of bone metabolism
Naot, D., & Cornish, J. (2008) · Bone · doi:10.1016/j.bone.2008.07.003 · Cited by 182
Gastric Acid, Calcium Absorption, and Their Impact on Bone Health
Kopic, S., & Geibel, J. P. (2013) · Physiological Reviews · doi:10.1152/physrev.00015.2012 · Cited by 176
“Today we know that the transient effect of calcitonin on osteoclasts is attributable to a downregulation of surface calcitonin receptors and their synthesis (882, 1061, 1129, 1130).”
BackgroundThe Activity of Peptides of the Calcitonin Family in Bone
Naot, D., Musson, D. S., & Cornish, J. (2019) · Physiological Reviews · doi:10.1152/physrev.00066.2017 · Cited by 141
“The desensitization of the cells to calcitonin was found to be the result of a ligand-induced internalization of the CTR, as well as inhibition of de novo synthesis of the receptor, and has been confirmed in both human and murine osteoclast cultures (194, 212).”
BackgroundRaisz, L. G., & Rodan, G. A. (2003) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(02)00055-5 · Cited by 151
“on osteoclasts [30].”
Calcitonin Therapy in Osteoporosis
Muñoz‐Torres, M., Alonso, G., & Raya, P. M. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403020-00006 · Cited by 110
Metadata
- Authors
- Wada, S., Udagawa, N., Nagata, N., Martin, T. J., & Findlay, D. M.
- Affiliations
- St Vincents Institute of Medical Research (AU)
- Venue
- Endocrinology
- Publisher
- The Endocrine Society
- Published
- 1996-03
- Volume
- 137
- Issue
- 3
- Pages
- 1042-1048
- ISSN
- 0013-7227 (ISSN-L)
- 1945-7170
- OpenAlex
- W2163741449
- Cited by
- 47
- References
- 9
- Citations by year
- 2026: 1 · 2020: 1 · 2019: 1 · 2018: 1 · 2015: 2 · 2013: 2 · 2012: 2
- FWCI
- 1.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
- Keywords
- calcitonin receptor, receptor down-regulation, osteoclasts, bone resorption, receptor desensitization, tartrate-resistant acid phosphatase, salmon calcitonin, adenylate cyclase
- MeSH terms
- Animals, Base Sequence, Calcitonin, Cells, Cultured, Drug Resistance, Mice, Inbred C57BL, Molecular Sequence Data, Osteoclasts, Radioligand Assay, RNA, Messenger, Down-Regulation, Receptors, Calcitonin, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts. https://app.cochat.ai/papers/10.1210/endo.137.3.8603572
- The paper
- Wada, S., Udagawa, N., Nagata, N., Martin, T. J., & Findlay, D. M. (1996). Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts. Endocrinology. https://doi.org/10.1210/endo.137.3.8603572
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.